Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 1,024,203 |
|
|||||
| News | - | ||||||
| Day High | 784.00 | Low High |
|||||
| Day Low | 769.20 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -2.25 | -0.29% | 772.7546 | 12:36:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 777.00 | 769.20 | 784.00 | 775.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 32,599 | 1,024,203 | $ 776.23 | $ 795,019,102 | - | 419.80 - 800.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:36:27 | 1 | $ 773.018 | USD |
Eli Lilly (LLY) Options Flow Summary
Eli Lilly and Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 733.02B | 950.16M | - | 34.12B | 5.24B | 5.52 | 139.88 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eli Lilly News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 778.08 | 784.00 | 730.34 | 758.58 | 3,241,429 | -5.33 | -0.68% |
| 1 Month | 759.78 | 795.4975 | 718.30 | 752.54 | 2,879,755 | 12.97 | 1.71% |
| 3 Months | 756.00 | 800.78 | 718.30 | 762.18 | 2,897,760 | 16.75 | 2.22% |
| 6 Months | 615.02 | 800.78 | 561.65 | 686.41 | 3,067,210 | 157.73 | 25.65% |
| 1 Year | 431.77 | 800.78 | 419.80 | 600.78 | 3,012,000 | 340.98 | 78.97% |
| 3 Years | 196.17 | 800.78 | 191.75 | 396.54 | 2,993,352 | 576.58 | 293.92% |
| 5 Years | 115.84 | 800.78 | 101.36 | 280.95 | 3,321,551 | 656.91 | 567.09% |
Eli Lilly Description
| Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. |
